Burke Neurological Institute
Menu
Skip to main content
Our Team
Contact Us
Donate
Clinical Trials
Search form
Search
About Us
Conditions
Faculty / Research Labs & Core Facilities
News & Impact
Future Talent
Events
About Us
+
About the Institute
Our Mission & Vision
Our History
Our Leadership
Our Boards
Our Team
Affiliations & Partners
Funding Sources
Brand Toolkit
Research Compliance
Campus Guide
Covid-19 Guidelines for Vendors
Contact Us
Conditions
+
Neurological Conditions
Stroke
Spinal Cord Injury
Traumatic Brain Injury
Cerebral Palsy
Neurodegenerative Diseases
Retinal Degenerative Diseases
Neurological Recovery
Motor Recovery
Pain & Sensory Recovery
Cognitive Recovery
Vision Recovery
Find a Clinical Trial
Inquire About Trials
Research Registry
Center for Pain & Sensory
Center for Vision Repair
Resilience Program
Campus Guide
Faculty / Research Labs & Core Facilities
+
Research Labs & Cores
Cho Lab
Friel Lab
Gibson Lab
Hollis Lab
Marshel Lab
Prusky Lab
Ratan Lab
Sahni Lab
Travis Lab
Willis Lab
Yoshida Lab
Imaging Core
SCI Core
Research Methods
News & Impact
+
Recent News & Impact
News
Publications
Grants
Presentations
Future Talent
+
Programs & Opportunities
Open Job Positions
Summer Science
Intro to Neuroscience
NeuroAcademy
Postdoctoral Fellow
Graduate Medical Fellow
Undergraduate
High School
Events
+
Upcoming Events
Archived Events
Webinar Series
Gibson Lab
News & Impact
Focus
People
Projects
Impact
Clinical Trials
You are here
Home
>
Are the Metabolic and Mitochondrial Changes Central in the Pathophysiology of Alzheimer’s Disease?
Are the Metabolic and Mitochondrial Changes Central in the Pathophysiology of Alzheimer’s Disease?
PRESENTATION:
Conference
April 2016
Venue:
New York Neuropsychology Group Conference, New York, New York
Featured Researchers
Gary E. Gibson, Ph.D.
Lab Director
Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration
Professor
Weill Cornell Medicine
Associated
Research Labs:
Gibson Lab
Conditions & Recovery
Cognitive Recovery
Remember and speak clearly.
Neurodegenerative Diseases
Worldwide, 50 million people are living with Alzheimer's and other dementias.